Henrik W. Finnern

Patients’ preferences for treatment outcomes for advanced non-small cell lung cancer: A conjoint analysis

John F. P. Bridges, Ateesha F. Mohamed, Henrik W. Finnern et al. · Lung Cancer · 2012 · 141 citations

Oncology, Patients ’ Preferences, Cancer Management +8

Health-Related Quality of Life and Utility in Patients with Advanced Non–Small-Cell Lung Cancer: A Prospective Cross-Sectional Patient Survey in a Real-World Setting

C. Chouaïd, Jason Agulnik, Erdem Göker et al. · Journal of Thoracic Oncology · 2013 · 138 citations · Full text

The hospital cost of vertebral fractures in the EU: estimates using national datasets

Henrik W. Finnern, David P. Sykes · Osteoporosis International · 2003 · 92 citations

Skeletal Trauma, Hospital Cost, Health Economics +11

Symptom and Quality of Life Benefit of Afatinib in Advanced Non–Small-Cell Lung Cancer Patients Previously Treated with Erlotinib or Gefitinib: Results of a Randomized Phase IIb/III Trial (LUX-Lung 1)

Vera Hirsh, J. Cadranel, Xiuyu Julie Cong et al. · Journal of Thoracic Oncology · 2013 · 77 citations · Full text

Life Benefit, Medicine, Cancer Management +6

Treatment patterns, use of resources, and costs of advanced non-small-cell lung cancer patients in Spain: results from a Delphi panel

Dolores Isla, Núria González-Rojas, Diana Nieves et al. · Clinical & Translational Oncology · 2011 · 54 citations

Oncology, Health Economics, Health Policy +9